Sight Sciences, Inc.
SGHT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $182,488 | $250,925 | $584,237 | $834,658 |
| - Cash | $120,357 | $138,129 | $185,000 | $260,687 |
| + Debt | $40,362 | $35,414 | $34,981 | $34,206 |
| Enterprise Value | $102,493 | $148,210 | $434,218 | $608,177 |
| Revenue | $79,866 | $81,056 | $71,331 | $48,956 |
| % Growth | -1.5% | 13.6% | 45.7% | – |
| Gross Profit | $68,285 | $69,175 | $58,970 | $40,346 |
| % Margin | 85.5% | 85.3% | 82.7% | 82.4% |
| EBITDA | -$45,897 | -$49,415 | -$80,477 | -$57,205 |
| % Margin | -57.5% | -61% | -112.8% | -116.8% |
| Net Income | -$51,507 | -$55,547 | -$86,242 | -$62,960 |
| % Margin | -64.5% | -68.5% | -120.9% | -128.6% |
| EPS Diluted | -1.03 | -1.14 | -1.8 | -1.33 |
| % Growth | 9.6% | 36.7% | -35.3% | – |
| Operating Cash Flow | -$22,351 | -$47,184 | -$75,965 | -$52,540 |
| Capital Expenditures | -$385 | -$791 | -$970 | -$813 |
| Free Cash Flow | -$22,736 | -$47,975 | -$76,935 | -$53,353 |